Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Altimmune, Inc. (ALT) had Free Cash Flow per Share of $-0.24 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-22.82M |
|
-- |
|
-- |
|
$26.23M |
|
$-26.23M |
|
$3.40M |
|
$-22.82M |
|
$-22.82M |
|
$-22.82M |
|
$-22.82M |
|
$-22.82M |
|
$-22.82M |
|
$-26.23M |
|
$-26.95M |
|
185.44M |
|
185.44M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$334.81M |
|
$0.06M |
|
$192.40M |
|
$527.21M |
|
$12.50M |
|
$34.74M |
|
$40.50M |
|
$53.00M |
|
$474.21M |
|
$474.21M |
|
$474.21M |
|
194.47M |
|
| Cash Flow Statement Financials | |
$-45.16M |
|
$-225.13M |
|
$289.54M |
|
$43.80M |
|
$63.05M |
|
$19.25M |
|
$6.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.78 |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.81% |
|
-4.81% |
|
-4.33% |
|
-4.48% |
|
$2.44 |
|
|
Free Cash Flow per Share |
$-0.24 |
$-0.24 |
|